Scilex Holding Company

DB:D8B0 Stock Report

Market Cap: €34.5m

Scilex Holding Management

Management criteria checks 1/4

Scilex Holding's CEO is Henry Ji, appointed in Aug 2025, has a tenure of 2.92 years. total yearly compensation is $3.07M, comprised of 50.7% salary and 49.3% bonuses, including company stock and options. directly owns 0.28% of the company’s shares, worth €95.44K. The average tenure of the management team and the board of directors is 3.8 years and 2.9 years respectively.

Key information

Henry Ji

Chief executive officer

US$3.1m

Total compensation

CEO salary percentage50.75%
CEO tenure1yr
CEO ownership0.3%
Management average tenure3.8yrs
Board average tenure2.9yrs

Recent management updates

Recent updates

CEO Compensation Analysis

How has Henry Ji's remuneration changed compared to Scilex Holding's earnings?
DateTotal CompensationSalaryCompany Earnings
Jun 30 2026n/an/a

-US$533m

Mar 31 2026n/an/a

-US$420m

Dec 31 2025US$3mUS$2m

-US$402m

Sep 30 2025n/an/a

-US$376m

Jun 30 2025n/an/a

-US$123m

Mar 31 2025n/an/a

-US$75m

Dec 31 2024US$1mUS$1m

-US$73m

Sep 30 2024n/an/a

-US$88m

Jun 30 2024n/an/a

-US$172m

Mar 31 2024n/an/a

-US$161m

Dec 31 2023US$34mUS$821k

-US$167m

Sep 30 2023n/an/a

-US$163m

Jun 30 2023n/an/a

-US$54m

Mar 31 2023n/an/a

-US$45m

Dec 31 2022US$4mUS$627k

-US$23m

Compensation vs Market: Henry's total compensation ($USD3.07M) is above average for companies of similar size in the German market ($USD405.52K).

Compensation vs Earnings: Henry's compensation has increased whilst the company is unprofitable.

CEO

Henry Ji (62 yo)

1yr
Tenure
US$3,069,495
Compensation

Dr. Henry H. Ji, Ph D., is Executive Chairperson of Semnur Pharmaceuticals, Inc. from September 22, 2025 and is its Chief Executive Officer and President from March 13, 2026. He is a Director at JP 3E Hold...

Leadership Team

NamePositionTenureCompensationOwnership
Henry Ji
CEO, President & Executive Chairman1yrUS$3.07m0.28%
€ 95.4k
Stephen Ma
Senior VP2.9yrsUS$1.47m0.0093%
€ 3.2k
Suketu Desai
Interim Chief Technical Officer & Senior VP3.8yrsno datano data
Gigi DeGuzman
VP & Chief People Officerno datano datano data
Suresh Khemani
Senior VP7.4yrsUS$456.82kno data
Dmitri Lissin
Senior VP of Clinical Development and Medical Affairs & Interim Chief Medical Officer3.8yrsUS$528.83kno data
3.8yrs
Average Tenure
62yo
Average Age

Experienced Management: D8B0's management team is considered experienced (3.8 years average tenure).

Board Members

NamePositionTenureCompensationOwnership
Henry Ji
CEO, President & Executive Chairman2.9yrsUS$3.07m0.28%
€ 95.4k
Stephen Ma
Senior VPless than a yearUS$1.47m0.0093%
€ 3.2k
Yue Wu
Independent Director2.9yrsUS$391.28k0.010%
€ 3.5k
Dorman Followwill
Independent Director3.8yrsUS$418.53k0.00092%
€ 317.5
Jay Chun
Independent Director2.9yrsUS$422.37k0.046%
€ 15.8k
2.9yrs
Average Tenure
62yo
Average Age

Experienced Board: D8B0's board of directors are not considered experienced ( 2.9 years average tenure), which suggests a new board.

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/23 08:01
End of Day Share Price 2026/08/21 00:00
Earnings2026/06/30
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Scilex Holding Company is covered by 2 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Mayank MamtaniB. Riley Securities, Inc.
Jason KolbertD. Boral Capital LLC.